Skip to main content

Advertisement

ADVERTISEMENT

Department

Conference Insider
05/07/2018
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018...
05/07/2018
First Report Managed Care

Advertisement

Conference Insider
05/07/2018
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation...
05/07/2018
First Report Managed Care

Advertisement

Conference Insider
05/07/2018
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson,...
05/07/2018
First Report Managed Care
News Connection
05/07/2018
After David Shulkin, MD, was abruptly fired by President Donald Trump, he claimed he was pushed out of the Department of Veterans Affairs (VA) by political opponents who saw him as a obstacle to expanding privatization of care at the Agency.
After David Shulkin, MD, was abruptly fired by President Donald Trump, he claimed he was pushed out of the Department of Veterans Affairs (VA) by political opponents who saw him as a obstacle to expanding privatization of care at the Agency.
After David Shulkin, MD, was...
05/07/2018
First Report Managed Care
News Connection
05/07/2018
A recent report released by the American Antitrust Institute (AAI) alerted the Department of Justice (DOJ) that the proposed merger of CVS and Aetna would hurt consumers and the health care industry.
A recent report released by the American Antitrust Institute (AAI) alerted the Department of Justice (DOJ) that the proposed merger of CVS and Aetna would hurt consumers and the health care industry.
A recent report released by the...
05/07/2018
First Report Managed Care

Advertisement

News Connection
05/07/2018
Boehringer Ingelheim and Eli Lilly recently announced that they plan to expand trials of Jardiance (empagliflozin; Boehringer Ingelheim/Eli Lilly) to study impact on exercise ability and heart failure symptoms. 
Boehringer Ingelheim and Eli Lilly recently announced that they plan to expand trials of Jardiance (empagliflozin; Boehringer Ingelheim/Eli Lilly) to study impact on exercise ability and heart failure symptoms. 
Boehringer Ingelheim and Eli...
05/07/2018
First Report Managed Care
News Connection
05/07/2018
A recent study in Genetics in Medicine found that genome sequencing in healthy patients and cardiology patients did not increase downstream health care costs.
A recent study in Genetics in Medicine found that genome sequencing in healthy patients and cardiology patients did not increase downstream health care costs.
A recent study in Genetics in...
05/07/2018
First Report Managed Care
Formulary Frontlines®
05/07/2018
Multiple sclerosis (MS) is chronic, inflammatory immune-mediated disease in which the immune system mistakenly attacks myelin in the central nervous system.
Multiple sclerosis (MS) is chronic, inflammatory immune-mediated disease in which the immune system mistakenly attacks myelin in the central nervous system.
Multiple sclerosis (MS) is...
05/07/2018
First Report Managed Care

Advertisement

Advertisement